Top Markets
Coin of the day
VectivBio Holding AG VectivBio Holding AG

VectivBio Holding AG

VECT
Ранг среди акций #14772
VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to... VectivBio Holding AG is a clinical-stage biopharmaceutical firm committed to identifying, developing, and commercializing treatments for severe rare medical conditions. The company's primary therapeutic focus is apraglutide, a prolonged-acting synthetic peptide analog of glucagon-like peptide-2. This compound is currently in a Phase III clinical trial for individuals with short bowel syndrome-intestinal failure (SBS-IF), and is also being evaluated in a Phase II clinical trial for SBS-IF patients with colon-in-continuity anatomy. Furthermore, apraglutide is undergoing a Phase II clinical study for patients experiencing steroid-refractory gastrointestinal acute graft-versus-host disease (aGvHD). Founded in 2019, VectivBio's corporate headquarters are situated in Basel, Switzerland.
Цена акции
$16.85
Последняя синхронизация: 2023-07-07
Рыночная капитализация
$393.50M
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
CH
Торговля VectivBio Holding AG (VECT)

Категория

История цены акций VectivBio Holding AG (VECT)
Наивысшая цена закрытия: $16.72 2023-07-01

Наименьшая цена закрытия: $16.68 2021-04-01
История цены акций VectivBio Holding AG с 2021 по 2026
Годовая динамика цены акций
Год Результативность
2023 96.64%
2022 112.95%
2021 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$544.38 39.22%
US
$1.03K 45.21%
NL
$121.37 -11.93%
AU
$138.80 476.17%
US
$749.64 5.07%
CH